pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,008 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT03096743: Evaluating Raised Intracranial Pressure Using MR Elastography

Sponsor: Mayo Clinic. Phase: NA. Conditions: Idiopathic Intracranial Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT06383143: Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: AL Amyloidosis, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

full page →ctgov ↗
›COMPLETEDphase readoutNCT04303078: Quantifying Energetic Demands of Walking for People With Cerebral Palsy

Sponsor: University of Washington. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06689085: 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Sponsor: Halozyme Therapeutics. Phase: PHASE3. Conditions: Hypogonadism, Male

full page →ctgov ↗
›RECRUITINGphase readoutNCT07424885: BeFlared Versus VBX for FEVAR

Sponsor: Medical University of Vienna. Phase: NA. Conditions: Fenestrated Endovascular Aortic Repair

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07428785: Pulmonary and Total Blood Volume in COPD

Sponsor: Rigshospitalet, Denmark. Phase: . Conditions: COPD (Chronic Obstructive Pulmonary Disease), Healthy Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT05067543: Perform Humeral System Study

Sponsor: Stryker Trauma and Extremities. Phase: . Conditions: Osteoarthritis Shoulder, Avascular Necrosis, Post-traumatic Arthrosis of Other Joints, Shoulder Region, Rotator Cuff Tear Arthropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07319078: Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction

Sponsor: Karolinska Institutet. Phase: NA. Conditions: Irritable Bowel Disease, Functional Abdominal Pain - Not Otherwise Specified (FAP-NOS), Functional Dyspepsia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07459608: Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent Lymphoma

Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Indolent Lymphoma, WM, MZL, CLL / SLL

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04902508: Evaluation of an Explicit Approach

Sponsor: University of Minnesota. Phase: NA. Conditions: Developmental Language Disorder, Explicit Intervention, Grammatical Language

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07487025: Knowledge, Coping Strategies, and Sexual Function in Chronic Pelvic Pain

Sponsor: Maria Blanco Diaz. Phase: . Conditions: Chronic Pelvic Pain, Chronic Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT06839625: The Effect of Emotional FreedomTechnique on Postoperative Pain, Pain Belief and Anxiety in Coronary Artery Bypass Graft Planned Patients

Sponsor: Ondokuz Mayıs University. Phase: NA. Conditions: Coronary Arterial Disease (CAD), Surgery (Cardiac), Emotional Freedom Technique

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04207476: Magnesphere for Autonomic Alteration

Sponsor: University of Oklahoma. Phase: NA. Conditions: Hart Failure With Reduced Ejection Fraction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07567976: Tai Chi Intervention for Balance Function in Older Adults: Predictive and Modifying Roles of Circadian Age

Sponsor: Zhide Liang. Phase: NA. Conditions: Aging, Postural Balance, Accidental Falls

full page →ctgov ↗
›RECRUITINGphase readoutNCT07406217: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

Sponsor: Calmy Alexandra. Phase: PHASE2. Conditions: COVID-19, Immunodeficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07053917: Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Stroke, Chronic Stroke, Intracerebral Haemorrhage, Intracerebral Haemorrhage (ICH), Intracerebral Hemorrhage Basal Ganglia, Ischemic Stroke, Ischemic Stroke and Hemorrhagic Stroke, Hemiparesis After Stroke, Hemiplegia Following Ischemic Stroke, Hemiplegia and Hemiparesis, Hemiplegia and/or Hemiparesis Following Stroke, Middle Cerebral Artery Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07315217: Cortical Excitability and Role of Non Invasive Brain Stimulation in ADHD and AUTISM

Sponsor: Assiut University. Phase: NA. Conditions: Cortical Excitability, Brain Stimulation, ADHD, Autism

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07483840: Analgesic Techniques for Robotic Prostatectomy Procedures

Sponsor: Ente Ospedaliero Ospedali Galliera. Phase: NA. Conditions: Postoperative Analgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04475640: Cancer Genetic Testing in Ethnic Populations

Sponsor: Mayo Clinic. Phase: NA. Conditions: Breast Carcinoma, Carcinoma of Unknown Primary, Central Nervous System Carcinoma, Digestive System Carcinoma, Genitourinary System Carcinoma, Head and Neck Carcinoma, Malignant Brain Neoplasm, Malignant Female Reproductive System Neoplasm, Malignant Musculoskeletal Neoplasm, Malignant Solid Neoplasm, Skin Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07264140: Assessing and Improving Misuse of Inhalers in COPD Outpatients

Sponsor: Hôpital Fribourgeois. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07038889: Overground Virtual Reality (VR) Gait Rehabilitation for Traumatic Brain Injury (TBI)

Sponsor: Indiana University. Phase: NA. Conditions: Traumatic Brain Injury, Stroke, Gait Training

full page →ctgov ↗
›RECRUITINGphase readoutNCT07471789: Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Sponsor: Gyala Therapeutics. Phase: PHASE1. Conditions: Acute Myeloblastic Leukaemia, Leukemia, T-Cell

full page →ctgov ↗
›RECRUITINGphase readoutNCT06373289: Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT06634368: Pilot Study of Hospital GamePlan4Care

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Caregivers

full page →ctgov ↗
›SUSPENDEDphase readoutNCT07285668: Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Hematologic Malignancies

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522268: Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy

Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University. Phase: PHASE3. Conditions: Pulpotomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07554768: Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC

Sponsor: Chen Chunyan. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07389850: Evaluation of the Evolution of Proprioceptive Reweighting Abilities Following Anterior Cruciate Ligament Reconstruction Surgery

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Anterior Cruciate Ligament Rupture With Ligamentoplasty

full page →ctgov ↗
›RECRUITINGphase readoutNCT07404774: Hemorrhoid Suture Mucopexy Combined With Laser Hemorrhoidoplasty

Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Haemorrhoid, Haemorrhoidal Bleeding, Anorectal Surgeries, Anorectal Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT04624490: Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Sponsor: Mario Castro, MD, MPH. Phase: PHASE1. Conditions: Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, Pulmonary Infection, Other Lung Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04685590: Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Alzheimer Disease, Early Onset, Mild Cognitive Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07256197: PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

Sponsor: Beijing Anzhen Hospital. Phase: PHASE3. Conditions: Aortic Stenosis, Calcific

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06136897: Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07478497: 30 Day Insulin Balance Metabolic Health Optimization Protocol

Sponsor: Efforia, Inc. Phase: NA. Conditions: Insulin

full page →ctgov ↗
›RECRUITINGphase readoutNCT05769010: Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Metastatic Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07405710: Use of the Electronic Medical Record to Screen Code Status Preference Using Death Language

Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Code Status Discussions With Medical In-patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT06376513: Evaluation of Penile Prosthesis Pump Manipulation

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Penile Prosthesis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06325020: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Sponsor: University of Edinburgh. Phase: . Conditions: Angina, Stable, Coronary Artery Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07518420: Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Non-erosive Reflux Disease (NERD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460960: TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Sponsor: Lomonosov Moscow State University Medical Research and Educational Center. Phase: PHASE2. Conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, Testosterone

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06973720: A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Sponsor: Metsera, a wholly owned subsidiary of Pfizer. Phase: PHASE2. Conditions: Obesity, Overweight or Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT05195138: Mindfulness-Based Diabetes Education for Adults With Elevated Diabetes Distress

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07231458: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies

Sponsor: Abalos Therapeutics GmbH. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476248: The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Sponsor: Assiut University. Phase: . Conditions: Diabetic Nephropathy, Dyslipidemia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06204614: Drug Screening Using IMD in Bladder Cancer

Sponsor: Brigham and Women's Hospital. Phase: EARLY_PHASE1. Conditions: Muscle Invasive Bladder Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07531706: Cortical Tracking of Speech in the First Year of Life

Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Language Development, Language Development Disorders, Infant Development, Infant Developmental Assessment

full page →ctgov ↗
›COMPLETEDphase readoutNCT06758206: Flywheel Resistance Training and Traditional Resistance Training in Older Women With Sedentary Behaviors

Sponsor: Federal University of Vicosa. Phase: NA. Conditions: Depressive Symptoms, Physical Function, Executive Function, Resistance Training

full page →ctgov ↗
›COMPLETEDphase readoutNCT07496684: Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules

Sponsor: Ma Zhe. Phase: . Conditions: Thyroid Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03837184: Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies

Sponsor: Novartis Gene Therapies. Phase: PHASE3. Conditions: Spinal Muscular Atrophy Type I

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583784: Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI

Sponsor: Chonnam National University Hospital. Phase: NA. Conditions: Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, AF - Atrial Fibrillation

full page →ctgov ↗
← prev
page 85 of 161
next →